| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Hershberg Robert is a Director at RXRX with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $903K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | ADPT Adaptive Biotechnologies Corp | Director | Sell | 22,968 | $16.00 | $367,488.00 | -33.0% | -7.8% | - | |
| Mar 12, 2025 | ADPT Adaptive Biotechnologies Corp | Director | Sell | 53,000 | $7.59 | $402,270.00 | -43.2% | +37.3% | +63.4% | |
| Jun 3, 2022 | FATE Fate Therapeutics Inc | Director | Sell | 672 | $22.75 | $15,288.00 | -25.1% | +14.3% | -77.8% | |
| Mar 8, 2021 | ADPT Adaptive Biotechnologies Corp | Director | Sale+OE | 2,000 | $44.56 | $89,120.00 | -100% | -1.0% | -69.3% | |
| Mar 8, 2021 | ADPT Adaptive Biotechnologies Corp | Director | Sale+OE | 2,000 | $44.56 | $89,120.00 | -57.1% | -1.0% | -69.3% | |
| Feb 16, 2021 | ADPT Adaptive Biotechnologies Corp | Director | Sale+OE | 2,000 | $65.45 | $130,900.00 | -57.1% | -46.4% | -75.9% | |
| Jan 15, 2021 | ADPT Adaptive Biotechnologies Corp | Director | Sale+OE | 2,000 | $66.56 | $133,121.62 | -76.3% | - | - | |
| Dec 15, 2020 | ADPT Adaptive Biotechnologies Corp | Director | Sale+OE | 2,000 | $55.93 | $111,856.43 | -89.2% | - | - | |
| Nov 16, 2020 | ADPT Adaptive Biotechnologies Corp | Director | Sale+OE | 2,000 | $47.69 | $95,380.63 | -90.0% | - | - | |
| Oct 15, 2020 | ADPT Adaptive Biotechnologies Corp | Director | Sale+OE | 2,000 | $51.51 | $103,020.00 | -100% | - | - |